General Information of DTT (ID: TTT4SY6)

DTT Name Hepatitis B virus Polymerase (HBV P) DTT Info
Gene Name HBV P

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Discontinued Drug(s)
Approved Drug(s)
Clinical Trial Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Telbivudine DMSWUGE Hepatitis B virus infection 1E51.0 Approved [1]
------------------------------------------------------------------------------------
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ATI-2173 DMT5QYJ Hepatitis B 1E51 Phase 2 [2]
NCO-48 DMUSPW5 Hepatitis B virus infection 1E51.0 Phase 1 [3]
------------------------------------------------------------------------------------
1 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valtorcitabine DMXQCBU Hepatitis virus infection 1E50-1E51 Discontinued in Phase 2 [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success. Best Pract Res Clin Gastroenterol. 2008;22(6):1081-92.
2 ATI-2173, a Novel Liver-Targeted Non-Chain-Terminating Nucleotide for Hepatitis B Virus Cure Regimens. Antimicrob Agents Chemother. 2020 Aug 20;64(9):e00836-20.
3 Safety, Tolerability and Pharmacokinetics of NCO-48 Fumarate in Healthy Subjects
4 Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting. J Pharm Sci. 2008 Mar;97(3):1109-34.